reference/2642941

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2642941

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	370
issn	0920-3206 1573-7241
issueIdentifier	3
pageRange	357-370
publicationName	Cardiovascular Drugs and Therapy
startingPage	357
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ce2ccb36242da64f2c9109c506f63206
bibliographicCitation	Judge DP, Kristen AV, Grogan M, Maurer MS, Falk RH, Hanna M, Gillmore J, Garg P, Vaishnaw AK, Harrop J, Powell C, Karsten V, Zhang X, Sweetser MT, Vest J, Hawkins PN. Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR). Cardiovascular Drugs and Therapy. 2020 Feb 15;34(3):357–70. doi: 10.1007/s10557-019-06919-4.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63cbd59053330b28c45b0c1216c44a8b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef40e81d01700b1cc47d9bfc6e0ddaed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_103f66711f70b650e4060665e0cbb148 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b078348bf53f8ec5904eb79453b7524 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2fc5bfbdc508a57e19350255d0bb91b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_926398deea32047cca8165ebe37a8bb9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d67f68cd488c7333c7806423424e17fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a11fb7dde572be36665863a20174605 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c3f29e9094c98ea3d676ef2d4872d823 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16fec215ad67563eb085f12afa144e7f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_861c95d01e0646be4d7e16f206eb6d78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7da3a3c3e15fd80f0a3603928bd8a9ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f02fea258ab1b660853fcc3a7acf0360 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3769fbcf6bddc52de49a0ecc30158e9b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc08994c5ebbc5ae982fb8734e9d21d7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16e50495893cadf39e63939d803aeb4f
date	2020-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s10557-019-06919-4 https://pubmed.ncbi.nlm.nih.gov/PMC7242280 https://pubmed.ncbi.nlm.nih.gov/32062791
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1847 https://portal.issn.org/resource/ISSN/0920-3206 https://portal.issn.org/resource/ISSN/1573-7241
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
discusses	http://id.nlm.nih.gov/mesh/M0406100 http://id.nlm.nih.gov/mesh/M000626604 http://id.nlm.nih.gov/mesh/M0017446 http://id.nlm.nih.gov/mesh/M000647713 http://id.nlm.nih.gov/mesh/C567782
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_da1ca8f34cf9fa260557c3847aa16ec1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7922 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8563 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6864

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7276

Total number of triples: 48.